

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ribosomal small subunit assembly (GO:0000028) | 8.21288746 |
| 2 | viral transcription (GO:0019083) | 7.09716220 |
| 3 | translational termination (GO:0006415) | 6.72781697 |
| 4 | ribosomal small subunit biogenesis (GO:0042274) | 6.65352528 |
| 5 | chaperone-mediated protein transport (GO:0072321) | 6.22089424 |
| 6 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 5.99065090 |
| 7 | cotranslational protein targeting to membrane (GO:0006613) | 5.91737525 |
| 8 | protein targeting to ER (GO:0045047) | 5.85293589 |
| 9 | translational elongation (GO:0006414) | 5.83834128 |
| 10 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 5.67675591 |
| 11 | protein localization to endoplasmic reticulum (GO:0070972) | 5.63262912 |
| 12 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 5.56578261 |
| 13 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 5.52212086 |
| 14 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 5.33359350 |
| 15 | maturation of SSU-rRNA (GO:0030490) | 5.30603085 |
| 16 | viral life cycle (GO:0019058) | 5.27716089 |
| 17 | ATP synthesis coupled proton transport (GO:0015986) | 5.20779524 |
| 18 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 5.20779524 |
| 19 | regulation of mitochondrial translation (GO:0070129) | 5.11221565 |
| 20 | cellular protein complex disassembly (GO:0043624) | 5.01571303 |
| 21 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 4.97056482 |
| 22 | mitochondrial respiratory chain complex assembly (GO:0033108) | 4.92419164 |
| 23 | negative regulation of telomere maintenance (GO:0032205) | 4.90508269 |
| 24 | respiratory electron transport chain (GO:0022904) | 4.88319163 |
| 25 | electron transport chain (GO:0022900) | 4.80866115 |
| 26 | translational initiation (GO:0006413) | 4.67819177 |
| 27 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.58864189 |
| 28 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.58864189 |
| 29 | DNA damage response, detection of DNA damage (GO:0042769) | 4.55858503 |
| 30 | negative regulation of telomerase activity (GO:0051974) | 4.48708573 |
| 31 | protein-cofactor linkage (GO:0018065) | 4.47809480 |
| 32 | ribosomal large subunit biogenesis (GO:0042273) | 4.44173386 |
| 33 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.37106982 |
| 34 | protein complex disassembly (GO:0043241) | 4.26327108 |
| 35 | DNA deamination (GO:0045006) | 4.26023247 |
| 36 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.25822266 |
| 37 | base-excision repair, AP site formation (GO:0006285) | 4.15380941 |
| 38 | protein targeting to mitochondrion (GO:0006626) | 4.09987477 |
| 39 | establishment of protein localization to mitochondrion (GO:0072655) | 3.99972015 |
| 40 | macromolecular complex disassembly (GO:0032984) | 3.96984409 |
| 41 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.91506210 |
| 42 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.88410827 |
| 43 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.85597560 |
| 44 | protein targeting to membrane (GO:0006612) | 3.85457159 |
| 45 | translation (GO:0006412) | 3.81436914 |
| 46 | protein localization to mitochondrion (GO:0070585) | 3.74877599 |
| 47 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.65184297 |
| 48 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.64879564 |
| 49 | response to interferon-beta (GO:0035456) | 3.64589766 |
| 50 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 3.57539908 |
| 51 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.57155877 |
| 52 | metallo-sulfur cluster assembly (GO:0031163) | 3.49652184 |
| 53 | iron-sulfur cluster assembly (GO:0016226) | 3.49652184 |
| 54 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.46115207 |
| 55 | mRNA catabolic process (GO:0006402) | 3.45165630 |
| 56 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 3.40618080 |
| 57 | DNA replication checkpoint (GO:0000076) | 3.39147169 |
| 58 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 3.38700683 |
| 59 | respiratory chain complex IV assembly (GO:0008535) | 3.37471634 |
| 60 | peptidyl-histidine modification (GO:0018202) | 3.37112185 |
| 61 | regulation of telomerase activity (GO:0051972) | 3.34970019 |
| 62 | regulation of helicase activity (GO:0051095) | 3.33705812 |
| 63 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.26641461 |
| 64 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.25731052 |
| 65 | pyrimidine nucleotide catabolic process (GO:0006244) | 3.24954898 |
| 66 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 3.21584184 |
| 67 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 3.21248631 |
| 68 | ATP biosynthetic process (GO:0006754) | 3.21164736 |
| 69 | hydrogen ion transmembrane transport (GO:1902600) | 3.21082235 |
| 70 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.20967093 |
| 71 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 3.20570017 |
| 72 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.20517533 |
| 73 | protein neddylation (GO:0045116) | 3.20387239 |
| 74 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.20080859 |
| 75 | platelet dense granule organization (GO:0060155) | 3.14613352 |
| 76 | protein deneddylation (GO:0000338) | 3.13404345 |
| 77 | inner mitochondrial membrane organization (GO:0007007) | 3.11858763 |
| 78 | maturation of 5.8S rRNA (GO:0000460) | 3.10775258 |
| 79 | RNA catabolic process (GO:0006401) | 3.09896745 |
| 80 | proteasome assembly (GO:0043248) | 3.08858894 |
| 81 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 3.08675890 |
| 82 | tRNA methylation (GO:0030488) | 3.06647772 |
| 83 | spliceosomal snRNP assembly (GO:0000387) | 3.05326401 |
| 84 | negative regulation of ligase activity (GO:0051352) | 3.05116725 |
| 85 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.05116725 |
| 86 | mitochondrial transport (GO:0006839) | 3.04694296 |
| 87 | cellular response to type I interferon (GO:0071357) | 3.03205457 |
| 88 | type I interferon signaling pathway (GO:0060337) | 3.03205457 |
| 89 | regulation of gamma-delta T cell activation (GO:0046643) | 3.02052002 |
| 90 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.01991476 |
| 91 | negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244) | 3.01375514 |
| 92 | response to type I interferon (GO:0034340) | 3.01145774 |
| 93 | cullin deneddylation (GO:0010388) | 2.99263919 |
| 94 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.97385559 |
| 95 | intracellular protein transmembrane import (GO:0044743) | 2.96411694 |
| 96 | CTP biosynthetic process (GO:0006241) | 2.96107581 |
| 97 | CTP metabolic process (GO:0046036) | 2.96107581 |
| 98 | ribonucleoside triphosphate biosynthetic process (GO:0009201) | 2.95626088 |
| 99 | negative T cell selection (GO:0043383) | 2.95129904 |
| 100 | tRNA processing (GO:0008033) | 2.94223149 |
| 101 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.94089324 |
| 102 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.93821302 |
| 103 | 7-methylguanosine mRNA capping (GO:0006370) | 2.93598521 |
| 104 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.92875381 |
| 105 | cellular component biogenesis (GO:0044085) | 2.91143861 |
| 106 | proton transport (GO:0015992) | 2.90716618 |
| 107 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.89738812 |
| 108 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.89738812 |
| 109 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.89495403 |
| 110 | NIK/NF-kappaB signaling (GO:0038061) | 2.89141426 |
| 111 | GDP-mannose metabolic process (GO:0019673) | 2.87102912 |
| 112 | pseudouridine synthesis (GO:0001522) | 2.87065426 |
| 113 | positive regulation of lymphocyte apoptotic process (GO:0070230) | 2.85444716 |
| 114 | negative regulation of necroptotic process (GO:0060546) | 2.85391087 |
| 115 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.84462289 |
| 116 | interferon-gamma production (GO:0032609) | 2.84423688 |
| 117 | telomere maintenance via telomerase (GO:0007004) | 2.83820873 |
| 118 | RNA capping (GO:0036260) | 2.83459469 |
| 119 | 7-methylguanosine RNA capping (GO:0009452) | 2.83459469 |
| 120 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.83221258 |
| 121 | termination of RNA polymerase III transcription (GO:0006386) | 2.83221258 |
| 122 | positive regulation of ligase activity (GO:0051351) | 2.82821166 |
| 123 | hydrogen transport (GO:0006818) | 2.82209485 |
| 124 | formation of translation preinitiation complex (GO:0001731) | 2.81619272 |
| 125 | regulation of telomere maintenance via telomerase (GO:0032210) | 2.79671852 |
| 126 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.78851981 |
| 127 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.78851981 |
| 128 | NADH dehydrogenase complex assembly (GO:0010257) | 2.78851981 |
| 129 | cytochrome complex assembly (GO:0017004) | 2.78714140 |
| 130 | protein complex biogenesis (GO:0070271) | 2.78618163 |
| 131 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 2.78487553 |
| 132 | positive regulation of B cell differentiation (GO:0045579) | 2.78260783 |
| 133 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.77410529 |
| 134 | negative thymic T cell selection (GO:0045060) | 2.77296912 |
| 135 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.76120521 |
| 136 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.76120521 |
| 137 | UTP biosynthetic process (GO:0006228) | 2.75847442 |
| 138 | pyrimidine nucleoside triphosphate biosynthetic process (GO:0009148) | 2.75084183 |
| 139 | definitive hemopoiesis (GO:0060216) | 2.73268933 |
| 140 | establishment of protein localization to membrane (GO:0090150) | 2.72519754 |
| 141 | positive regulation of granulocyte differentiation (GO:0030854) | 2.71449663 |
| 142 | regulation of B cell differentiation (GO:0045577) | 2.71164590 |
| 143 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.70660303 |
| 144 | rRNA modification (GO:0000154) | 2.67369906 |
| 145 | rRNA methylation (GO:0031167) | 2.66831009 |
| 146 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.66550968 |
| 147 | pyrimidine ribonucleoside triphosphate biosynthetic process (GO:0009209) | 2.65416385 |
| 148 | regulation of regulatory T cell differentiation (GO:0045589) | 2.64043345 |
| 149 | B cell receptor signaling pathway (GO:0050853) | 2.62251714 |
| 150 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.60549202 |
| 151 | quinone biosynthetic process (GO:1901663) | 2.57504348 |
| 152 | ubiquinone biosynthetic process (GO:0006744) | 2.57504348 |
| 153 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.56569828 |
| 154 | cellular response to interferon-beta (GO:0035458) | 2.56334944 |
| 155 | GTP biosynthetic process (GO:0006183) | 2.55496364 |
| 156 | lymphoid progenitor cell differentiation (GO:0002320) | 2.54450923 |
| 157 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.53971292 |
| 158 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.53971292 |
| 159 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.53878985 |
| 160 | mature B cell differentiation involved in immune response (GO:0002313) | 2.53678223 |
| 161 | guanosine-containing compound biosynthetic process (GO:1901070) | 2.52391071 |
| 162 | cellular response to interleukin-15 (GO:0071350) | 2.51341952 |
| 163 | oxidative phosphorylation (GO:0006119) | 2.50430093 |
| 164 | T cell homeostasis (GO:0043029) | 2.50161775 |
| 165 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.49483112 |
| 166 | response to interferon-alpha (GO:0035455) | 2.49081766 |
| 167 | protein targeting (GO:0006605) | 2.47594942 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.84159287 |
| 2 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.69547372 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.50749569 |
| 4 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 3.31152855 |
| 5 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 3.13757017 |
| 6 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 3.08662545 |
| 7 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.08476054 |
| 8 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.98896667 |
| 9 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.98872867 |
| 10 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.92986326 |
| 11 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.84838551 |
| 12 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.81620986 |
| 13 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.76059211 |
| 14 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.74242358 |
| 15 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.62384181 |
| 16 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.58359454 |
| 17 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.56479119 |
| 18 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.53048738 |
| 19 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.46125263 |
| 20 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.38641420 |
| 21 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.32503692 |
| 22 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.30552201 |
| 23 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.30121179 |
| 24 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.27821729 |
| 25 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.25374391 |
| 26 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.23316001 |
| 27 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.15152275 |
| 28 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.10248276 |
| 29 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.08103020 |
| 30 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 2.07553108 |
| 31 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.04032500 |
| 32 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.02561625 |
| 33 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.02497333 |
| 34 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.01225054 |
| 35 | MYC_22102868_ChIP-Seq_BL_Human | 1.96042241 |
| 36 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.95341451 |
| 37 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.89656785 |
| 38 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.89216893 |
| 39 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.84853768 |
| 40 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.80344256 |
| 41 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.77162556 |
| 42 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.76849470 |
| 43 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.76342615 |
| 44 | MAF_26560356_Chip-Seq_TH1_Human | 1.75427089 |
| 45 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.67846525 |
| 46 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.66977716 |
| 47 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.66972845 |
| 48 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.64025622 |
| 49 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.63470824 |
| 50 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.63020231 |
| 51 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.61826812 |
| 52 | * MAF_26560356_Chip-Seq_TH2_Human | 1.55590986 |
| 53 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.54040607 |
| 54 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.53632830 |
| 55 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.53152831 |
| 56 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.52907507 |
| 57 | UTX_26944678_Chip-Seq_JUKART_Human | 1.48180355 |
| 58 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.45284340 |
| 59 | MYB_26560356_Chip-Seq_TH2_Human | 1.44513504 |
| 60 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.44169665 |
| 61 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.41604296 |
| 62 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.38033046 |
| 63 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.36314242 |
| 64 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.36191402 |
| 65 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.35895331 |
| 66 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.34386190 |
| 67 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.33434609 |
| 68 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.33326590 |
| 69 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.32256101 |
| 70 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.31882135 |
| 71 | * MYB_26560356_Chip-Seq_TH1_Human | 1.29429862 |
| 72 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.29208963 |
| 73 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.28418365 |
| 74 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.27081528 |
| 75 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.27034988 |
| 76 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.25913957 |
| 77 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.25840065 |
| 78 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.25685098 |
| 79 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.24906250 |
| 80 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.24613975 |
| 81 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.24377897 |
| 82 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.23963298 |
| 83 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.23234212 |
| 84 | GATA1_22025678_ChIP-Seq_K562_Human | 1.22483435 |
| 85 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.21165912 |
| 86 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.20055841 |
| 87 | * YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.19280017 |
| 88 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.19147952 |
| 89 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.18829933 |
| 90 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.18354058 |
| 91 | * ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.17471068 |
| 92 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.17414737 |
| 93 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.15281865 |
| 94 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.14635089 |
| 95 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.14337272 |
| 96 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.13992073 |
| 97 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 1.12151842 |
| 98 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.11764889 |
| 99 | * EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.11694736 |
| 100 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.11147835 |
| 101 | * P68_20966046_ChIP-Seq_HELA_Human | 1.09416999 |
| 102 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.08958315 |
| 103 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.08680906 |
| 104 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.07694476 |
| 105 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.07152933 |
| 106 | * YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.05950182 |
| 107 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.05825754 |
| 108 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.05644974 |
| 109 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.04766211 |
| 110 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.03780472 |
| 111 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.03715149 |
| 112 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.03162078 |
| 113 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.02833619 |
| 114 | * PHF8_20622854_ChIP-Seq_HELA_Human | 1.01549099 |
| 115 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.01292881 |
| 116 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.01098803 |
| 117 | * E2F1_20622854_ChIP-Seq_HELA_Human | 1.00864103 |
| 118 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.00419918 |
| 119 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.00353053 |
| 120 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.99382113 |
| 121 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.98339059 |
| 122 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.98174152 |
| 123 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.97039251 |
| 124 | * CTCF_20526341_ChIP-Seq_ESCs_Human | 0.96434408 |
| 125 | * SA1_27219007_Chip-Seq_Bcells_Human | 0.95433823 |
| 126 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.94170293 |
| 127 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.93503424 |
| 128 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.93114370 |
| 129 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.91615285 |
| 130 | ERA_21632823_ChIP-Seq_H3396_Human | 0.90416026 |
| 131 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.90156677 |
| 132 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.89997546 |
| 133 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.89905649 |
| 134 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 0.89626744 |
| 135 | * RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.89591641 |
| 136 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.88061243 |
| 137 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.87111341 |
| 138 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.86253138 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003763_abnormal_thymus_physiology | 4.05287277 |
| 2 | MP0009379_abnormal_foot_pigmentation | 3.96165097 |
| 3 | MP0005671_abnormal_response_to | 3.76032332 |
| 4 | MP0002396_abnormal_hematopoietic_system | 3.18388725 |
| 5 | MP0002132_abnormal_respiratory_system | 3.01918942 |
| 6 | MP0001835_abnormal_antigen_presentation | 2.81855862 |
| 7 | MP0000685_abnormal_immune_system | 2.74789832 |
| 8 | MP0003724_increased_susceptibility_to | 2.60786803 |
| 9 | MP0005075_abnormal_melanosome_morpholog | 2.54482384 |
| 10 | MP0009785_altered_susceptibility_to | 2.47713401 |
| 11 | MP0002277_abnormal_respiratory_mucosa | 2.46476817 |
| 12 | MP0002166_altered_tumor_susceptibility | 2.39664222 |
| 13 | MP0003786_premature_aging | 2.34549660 |
| 14 | MP0009333_abnormal_splenocyte_physiolog | 2.27426505 |
| 15 | MP0001529_abnormal_vocalization | 2.25130783 |
| 16 | MP0004381_abnormal_hair_follicle | 2.23566846 |
| 17 | MP0001800_abnormal_humoral_immune | 2.23346232 |
| 18 | MP0003693_abnormal_embryo_hatching | 2.21065574 |
| 19 | MP0006035_abnormal_mitochondrial_morpho | 2.20552970 |
| 20 | MP0005464_abnormal_platelet_physiology | 2.19744146 |
| 21 | MP0002420_abnormal_adaptive_immunity | 2.16520362 |
| 22 | MP0002723_abnormal_immune_serum | 2.15774491 |
| 23 | MP0002102_abnormal_ear_morphology | 2.13811386 |
| 24 | MP0002398_abnormal_bone_marrow | 2.10919546 |
| 25 | MP0001819_abnormal_immune_cell | 2.09903655 |
| 26 | MP0002837_dystrophic_cardiac_calcinosis | 2.03816855 |
| 27 | MP0001853_heart_inflammation | 2.03155505 |
| 28 | MP0005025_abnormal_response_to | 2.02150666 |
| 29 | MP0004808_abnormal_hematopoietic_stem | 1.99971447 |
| 30 | MP0002452_abnormal_antigen_presenting | 1.99513448 |
| 31 | MP0000465_gastrointestinal_hemorrhage | 1.96727006 |
| 32 | MP0005000_abnormal_immune_tolerance | 1.96149247 |
| 33 | MP0000716_abnormal_immune_system | 1.95948105 |
| 34 | MP0002722_abnormal_immune_system | 1.90265024 |
| 35 | MP0000689_abnormal_spleen_morphology | 1.89809300 |
| 36 | MP0000372_irregular_coat_pigmentation | 1.86535549 |
| 37 | MP0000703_abnormal_thymus_morphology | 1.82502955 |
| 38 | MP0001873_stomach_inflammation | 1.79171570 |
| 39 | MP0001188_hyperpigmentation | 1.78141801 |
| 40 | MP0008877_abnormal_DNA_methylation | 1.76403385 |
| 41 | MP0008995_early_reproductive_senescence | 1.74353901 |
| 42 | MP0002095_abnormal_skin_pigmentation | 1.71898829 |
| 43 | MP0005387_immune_system_phenotype | 1.71862280 |
| 44 | MP0001790_abnormal_immune_system | 1.71862280 |
| 45 | MP0002736_abnormal_nociception_after | 1.69884305 |
| 46 | MP0003866_abnormal_defecation | 1.68825047 |
| 47 | MP0002148_abnormal_hypersensitivity_rea | 1.68779326 |
| 48 | MP0002429_abnormal_blood_cell | 1.68298013 |
| 49 | MP0004133_heterotaxia | 1.67904661 |
| 50 | MP0003646_muscle_fatigue | 1.63889326 |
| 51 | MP0002405_respiratory_system_inflammati | 1.61475984 |
| 52 | MP0003111_abnormal_nucleus_morphology | 1.61265526 |
| 53 | MP0002006_tumorigenesis | 1.60870867 |
| 54 | MP0004142_abnormal_muscle_tone | 1.58963892 |
| 55 | MP0002653_abnormal_ependyma_morphology | 1.55466990 |
| 56 | MP0008004_abnormal_stomach_pH | 1.54454450 |
| 57 | MP0003880_abnormal_central_pattern | 1.53648946 |
| 58 | MP0010155_abnormal_intestine_physiology | 1.49150627 |
| 59 | MP0001919_abnormal_reproductive_system | 1.47724550 |
| 60 | MP0005174_abnormal_tail_pigmentation | 1.47215795 |
| 61 | MP0006082_CNS_inflammation | 1.46728073 |
| 62 | MP0002419_abnormal_innate_immunity | 1.46159276 |
| 63 | MP0002933_joint_inflammation | 1.43066039 |
| 64 | MP0000049_abnormal_middle_ear | 1.42108778 |
| 65 | MP0003136_yellow_coat_color | 1.41365461 |
| 66 | MP0001905_abnormal_dopamine_level | 1.41017434 |
| 67 | MP0002009_preneoplasia | 1.38579017 |
| 68 | MP0000343_altered_response_to | 1.37206125 |
| 69 | MP0006292_abnormal_olfactory_placode | 1.25943497 |
| 70 | MP0008875_abnormal_xenobiotic_pharmacok | 1.25384229 |
| 71 | MP0001764_abnormal_homeostasis | 1.24137590 |
| 72 | MP0003137_abnormal_impulse_conducting | 1.23850911 |
| 73 | MP0003191_abnormal_cellular_cholesterol | 1.23028855 |
| 74 | MP0005389_reproductive_system_phenotype | 1.22570748 |
| 75 | MP0009745_abnormal_behavioral_response | 1.20722305 |
| 76 | MP0010094_abnormal_chromosome_stability | 1.19879979 |
| 77 | MP0008469_abnormal_protein_level | 1.18444970 |
| 78 | MP0008932_abnormal_embryonic_tissue | 1.18055402 |
| 79 | MP0004947_skin_inflammation | 1.17222594 |
| 80 | MP0005646_abnormal_pituitary_gland | 1.15907866 |
| 81 | MP0001986_abnormal_taste_sensitivity | 1.15019628 |
| 82 | MP0003436_decreased_susceptibility_to | 1.14889007 |
| 83 | MP0004145_abnormal_muscle_electrophysio | 1.14536017 |
| 84 | MP0000490_abnormal_crypts_of | 1.14276601 |
| 85 | MP0009046_muscle_twitch | 1.12647550 |
| 86 | MP0001845_abnormal_inflammatory_respons | 1.12509350 |
| 87 | MP0000749_muscle_degeneration | 1.12397004 |
| 88 | MP0003787_abnormal_imprinting | 1.12307485 |
| 89 | MP0005058_abnormal_lysosome_morphology | 1.10938904 |
| 90 | MP0006276_abnormal_autonomic_nervous | 1.10132341 |
| 91 | MP0005397_hematopoietic_system_phenotyp | 1.09923368 |
| 92 | MP0001545_abnormal_hematopoietic_system | 1.09923368 |
| 93 | MP0001968_abnormal_touch/_nociception | 1.09156592 |
| 94 | MP0005367_renal/urinary_system_phenotyp | 1.07584075 |
| 95 | MP0000516_abnormal_urinary_system | 1.07584075 |
| 96 | MP0002160_abnormal_reproductive_system | 1.07406170 |
| 97 | MP0003315_abnormal_perineum_morphology | 1.06841164 |
| 98 | MP0003806_abnormal_nucleotide_metabolis | 1.05865738 |
| 99 | MP0006072_abnormal_retinal_apoptosis | 1.05825826 |
| 100 | MP0003828_pulmonary_edema | 1.04283546 |
| 101 | MP0008058_abnormal_DNA_repair | 1.02971330 |
| 102 | MP0005394_taste/olfaction_phenotype | 1.02838449 |
| 103 | MP0005499_abnormal_olfactory_system | 1.02838449 |
| 104 | MP0005409_darkened_coat_color | 1.02476070 |
| 105 | MP0005551_abnormal_eye_electrophysiolog | 1.01757900 |
| 106 | MP0000681_abnormal_thyroid_gland | 1.00749555 |
| 107 | MP0009384_cardiac_valve_regurgitation | 0.98971040 |
| 108 | MP0003941_abnormal_skin_development | 0.98533689 |
| 109 | MP0006036_abnormal_mitochondrial_physio | 0.97683019 |
| 110 | MP0005410_abnormal_fertilization | 0.97049087 |
| 111 | MP0003077_abnormal_cell_cycle | 0.96435519 |
| 112 | MP0003172_abnormal_lysosome_physiology | 0.96253832 |
| 113 | MP0003279_aneurysm | 0.94762563 |
| 114 | MP0003303_peritoneal_inflammation | 0.93344743 |
| 115 | MP0008007_abnormal_cellular_replicative | 0.92448819 |
| 116 | MP0000631_abnormal_neuroendocrine_gland | 0.91546761 |
| 117 | MP0002938_white_spotting | 0.91467016 |
| 118 | MP0002163_abnormal_gland_morphology | 0.91309729 |
| 119 | MP0001243_abnormal_dermal_layer | 0.90957814 |
| 120 | MP0001851_eye_inflammation | 0.90713471 |
| 121 | MP0005670_abnormal_white_adipose | 0.90596199 |
| 122 | MP0009764_decreased_sensitivity_to | 0.90376546 |
| 123 | MP0005266_abnormal_metabolism | 0.89854694 |
| 124 | MP0002254_reproductive_system_inflammat | 0.89417066 |
| 125 | MP0003195_calcinosis | 0.87802908 |
| 126 | MP0002064_seizures | 0.87791019 |
| 127 | MP0002210_abnormal_sex_determination | 0.87228548 |
| 128 | MP0010030_abnormal_orbit_morphology | 0.86738362 |
| 129 | MP0003938_abnormal_ear_development | 0.85068447 |
| 130 | MP0005451_abnormal_body_composition | 0.84856051 |
| 131 | MP0001970_abnormal_pain_threshold | 0.84299595 |
| 132 | MP0004510_myositis | 0.82834484 |
| 133 | MP0000358_abnormal_cell_content/ | 0.81272720 |
| 134 | MP0005319_abnormal_enzyme/_coenzyme | 0.80303965 |
| 135 | MP0005023_abnormal_wound_healing | 0.80057622 |
| 136 | MP0004957_abnormal_blastocyst_morpholog | 0.80040267 |
| 137 | MP0001929_abnormal_gametogenesis | 0.79381038 |
| 138 | MP0005332_abnormal_amino_acid | 0.78795511 |
| 139 | MP0000858_altered_metastatic_potential | 0.78646764 |
| 140 | MP0003011_delayed_dark_adaptation | 0.77467801 |
| 141 | MP0001485_abnormal_pinna_reflex | 0.77035746 |
| 142 | MP0002019_abnormal_tumor_incidence | 0.76126387 |
| 143 | MP0002090_abnormal_vision | 0.75506299 |
| 144 | MP0000678_abnormal_parathyroid_gland | 0.73396980 |
| 145 | MP0003186_abnormal_redox_activity | 0.72458337 |
| 146 | MP0002249_abnormal_larynx_morphology | 0.72315337 |
| 147 | MP0000653_abnormal_sex_gland | 0.72271476 |
| 148 | MP0001145_abnormal_male_reproductive | 0.71651652 |
| 149 | MP0004147_increased_porphyrin_level | 0.71582396 |
| 150 | MP0002139_abnormal_hepatobiliary_system | 0.70828066 |
| 151 | MP0003943_abnormal_hepatobiliary_system | 0.70525709 |
| 152 | MP0009840_abnormal_foam_cell | 0.69419011 |
| 153 | MP0009765_abnormal_xenobiotic_induced | 0.69321351 |
| 154 | MP0005253_abnormal_eye_physiology | 0.68841950 |
| 155 | MP0002272_abnormal_nervous_system | 0.67948484 |
| 156 | MP0000747_muscle_weakness | 0.67591113 |
| 157 | MP0000313_abnormal_cell_death | 0.67102424 |
| 158 | MP0003698_abnormal_male_reproductive | 0.66616440 |
| 159 | MP0000015_abnormal_ear_pigmentation | 0.66433768 |
| 160 | MP0002876_abnormal_thyroid_physiology | 0.66151877 |
| 161 | MP0004036_abnormal_muscle_relaxation | 0.64697463 |
| 162 | MP0002060_abnormal_skin_morphology | 0.63946016 |
| 163 | MP0005084_abnormal_gallbladder_morpholo | 0.62970396 |
| 164 | MP0001216_abnormal_epidermal_layer | 0.59873719 |
| 165 | MP0003453_abnormal_keratinocyte_physiol | 0.59647700 |
| 166 | MP0001533_abnormal_skeleton_physiology | 0.58438266 |
| 167 | MP0009763_increased_sensitivity_to | 0.58336510 |
| 168 | MP0008789_abnormal_olfactory_epithelium | 0.58321930 |
| 169 | MP0004084_abnormal_cardiac_muscle | 0.57793951 |
| 170 | MP0002075_abnormal_coat/hair_pigmentati | 0.53605322 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormal number of erythroid precursors (HP:0012131) | 4.84247115 |
| 2 | Abnormality of cells of the erythroid lineage (HP:0012130) | 4.83589915 |
| 3 | Reticulocytopenia (HP:0001896) | 4.48042482 |
| 4 | Thrombocytosis (HP:0001894) | 4.09295991 |
| 5 | IgM deficiency (HP:0002850) | 3.86089467 |
| 6 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.70535562 |
| 7 | Cerebral edema (HP:0002181) | 3.62990806 |
| 8 | Hepatocellular necrosis (HP:0001404) | 3.51540133 |
| 9 | Macrocytic anemia (HP:0001972) | 3.46386908 |
| 10 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 3.23994617 |
| 11 | Type I transferrin isoform profile (HP:0003642) | 3.23930832 |
| 12 | Chronic otitis media (HP:0000389) | 3.22216843 |
| 13 | Petechiae (HP:0000967) | 3.20369253 |
| 14 | Hepatic necrosis (HP:0002605) | 3.17243007 |
| 15 | Mitochondrial inheritance (HP:0001427) | 3.16949227 |
| 16 | Aplastic anemia (HP:0001915) | 3.13290337 |
| 17 | Respiratory failure (HP:0002878) | 3.07774560 |
| 18 | Generalized aminoaciduria (HP:0002909) | 3.04718953 |
| 19 | Increased hepatocellular lipid droplets (HP:0006565) | 2.99051868 |
| 20 | Pallor (HP:0000980) | 2.93375151 |
| 21 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.91497219 |
| 22 | Recurrent bronchitis (HP:0002837) | 2.87284534 |
| 23 | Methylmalonic aciduria (HP:0012120) | 2.86953162 |
| 24 | Increased serum pyruvate (HP:0003542) | 2.86814275 |
| 25 | Type 2 muscle fiber atrophy (HP:0003554) | 2.85775986 |
| 26 | Prolonged bleeding time (HP:0003010) | 2.79990166 |
| 27 | Muscle fiber atrophy (HP:0100295) | 2.76043116 |
| 28 | Increased CSF lactate (HP:0002490) | 2.74937914 |
| 29 | Respiratory difficulties (HP:0002880) | 2.72498508 |
| 30 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.69184865 |
| 31 | Lipid accumulation in hepatocytes (HP:0006561) | 2.68321196 |
| 32 | Ragged-red muscle fibers (HP:0003200) | 2.67339109 |
| 33 | Optic disc pallor (HP:0000543) | 2.66855368 |
| 34 | Methylmalonic acidemia (HP:0002912) | 2.66731961 |
| 35 | Acute necrotizing encephalopathy (HP:0006965) | 2.59687352 |
| 36 | Nemaline bodies (HP:0003798) | 2.59399882 |
| 37 | Exertional dyspnea (HP:0002875) | 2.56782746 |
| 38 | Increased intramyocellular lipid droplets (HP:0012240) | 2.56192905 |
| 39 | IgG deficiency (HP:0004315) | 2.55033875 |
| 40 | Epistaxis (HP:0000421) | 2.53947620 |
| 41 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.53058209 |
| 42 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.53058209 |
| 43 | Renal Fanconi syndrome (HP:0001994) | 2.49151236 |
| 44 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.47818379 |
| 45 | Progressive muscle weakness (HP:0003323) | 2.44394324 |
| 46 | Abnormality of the nasal mucosa (HP:0000433) | 2.43908453 |
| 47 | Panhypogammaglobulinemia (HP:0003139) | 2.43611532 |
| 48 | Nasal polyposis (HP:0100582) | 2.42316549 |
| 49 | T lymphocytopenia (HP:0005403) | 2.41758346 |
| 50 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.41457351 |
| 51 | Emotional lability (HP:0000712) | 2.40793859 |
| 52 | Premature skin wrinkling (HP:0100678) | 2.39278131 |
| 53 | Abnormality of T cells (HP:0002843) | 2.39196540 |
| 54 | Chronic sinusitis (HP:0011109) | 2.38230388 |
| 55 | Muscle fiber inclusion bodies (HP:0100299) | 2.38081926 |
| 56 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.37562607 |
| 57 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.37562607 |
| 58 | Abnormal protein glycosylation (HP:0012346) | 2.37562607 |
| 59 | Abnormal glycosylation (HP:0012345) | 2.37562607 |
| 60 | CNS demyelination (HP:0007305) | 2.37194937 |
| 61 | Abnormality of glycolysis (HP:0004366) | 2.36907784 |
| 62 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.35770177 |
| 63 | Lethargy (HP:0001254) | 2.35036105 |
| 64 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.32791820 |
| 65 | Myositis (HP:0100614) | 2.31598051 |
| 66 | Microcytic anemia (HP:0001935) | 2.31576300 |
| 67 | 3-Methylglutaconic aciduria (HP:0003535) | 2.31166603 |
| 68 | Abnormality of urine glucose concentration (HP:0011016) | 2.30567616 |
| 69 | Glycosuria (HP:0003076) | 2.30567616 |
| 70 | Asplenia (HP:0001746) | 2.29722049 |
| 71 | Abnormality of renal resorption (HP:0011038) | 2.29719710 |
| 72 | Agammaglobulinemia (HP:0004432) | 2.27661006 |
| 73 | Abnormality of T cell number (HP:0011839) | 2.27352707 |
| 74 | Increased muscle lipid content (HP:0009058) | 2.27331843 |
| 75 | Cerebral hypomyelination (HP:0006808) | 2.27302676 |
| 76 | Purpura (HP:0000979) | 2.20238495 |
| 77 | Retinal dysplasia (HP:0007973) | 2.20011908 |
| 78 | Polyphagia (HP:0002591) | 2.19540008 |
| 79 | Lactic acidosis (HP:0003128) | 2.19205932 |
| 80 | Exercise intolerance (HP:0003546) | 2.19111565 |
| 81 | Nausea (HP:0002018) | 2.13965170 |
| 82 | Leukodystrophy (HP:0002415) | 2.13751024 |
| 83 | Broad face (HP:0000283) | 2.12265277 |
| 84 | Calcaneovalgus deformity (HP:0001848) | 2.11910033 |
| 85 | Parakeratosis (HP:0001036) | 2.11461810 |
| 86 | Hypothermia (HP:0002045) | 2.10359294 |
| 87 | Microvesicular hepatic steatosis (HP:0001414) | 2.09886192 |
| 88 | Hypoproteinemia (HP:0003075) | 2.09301089 |
| 89 | Increased serum lactate (HP:0002151) | 2.07375592 |
| 90 | 11 pairs of ribs (HP:0000878) | 2.05584782 |
| 91 | Type II lissencephaly (HP:0007260) | 2.05389061 |
| 92 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.05088840 |
| 93 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.02636685 |
| 94 | Acute encephalopathy (HP:0006846) | 2.02424891 |
| 95 | Reduced antithrombin III activity (HP:0001976) | 2.01726129 |
| 96 | Deformed tarsal bones (HP:0008119) | 2.01208563 |
| 97 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.01162943 |
| 98 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 2.00783647 |
| 99 | Hyperalaninemia (HP:0003348) | 2.00688222 |
| 100 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.00688222 |
| 101 | Abnormality of alanine metabolism (HP:0010916) | 2.00688222 |
| 102 | Weak cry (HP:0001612) | 2.00269021 |
| 103 | Impaired platelet aggregation (HP:0003540) | 1.98366930 |
| 104 | Abnormal platelet function (HP:0011869) | 1.98366930 |
| 105 | Abnormality of the labia minora (HP:0012880) | 1.97440631 |
| 106 | Seborrheic dermatitis (HP:0001051) | 1.96999903 |
| 107 | Abnormality of T cell physiology (HP:0011840) | 1.96342977 |
| 108 | Nonprogressive disorder (HP:0003680) | 1.93700200 |
| 109 | Hyperglycinemia (HP:0002154) | 1.93234063 |
| 110 | Lymphopenia (HP:0001888) | 1.92048164 |
| 111 | Pancytopenia (HP:0001876) | 1.90752126 |
| 112 | Microretrognathia (HP:0000308) | 1.90225113 |
| 113 | Progressive microcephaly (HP:0000253) | 1.89840393 |
| 114 | Severe combined immunodeficiency (HP:0004430) | 1.88460706 |
| 115 | Cerebral palsy (HP:0100021) | 1.87703752 |
| 116 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.85168145 |
| 117 | Recurrent cutaneous fungal infections (HP:0011370) | 1.85168145 |
| 118 | Abnormality of eosinophils (HP:0001879) | 1.83991866 |
| 119 | Dry hair (HP:0011359) | 1.82782210 |
| 120 | Abnormality of glycolipid metabolism (HP:0010969) | 1.82156406 |
| 121 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.82156406 |
| 122 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.82156406 |
| 123 | X-linked dominant inheritance (HP:0001423) | 1.80925013 |
| 124 | Meningitis (HP:0001287) | 1.80898627 |
| 125 | Vomiting (HP:0002013) | 1.80859148 |
| 126 | Granulocytopenia (HP:0001913) | 1.79584510 |
| 127 | Absent thumb (HP:0009777) | 1.79461386 |
| 128 | Dicarboxylic aciduria (HP:0003215) | 1.78401681 |
| 129 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.78401681 |
| 130 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.77094481 |
| 131 | Pustule (HP:0200039) | 1.76992653 |
| 132 | Thyroid-stimulating hormone excess (HP:0002925) | 1.76418961 |
| 133 | Hepatosplenomegaly (HP:0001433) | 1.76218830 |
| 134 | Encephalitis (HP:0002383) | 1.75718931 |
| 135 | Progressive macrocephaly (HP:0004481) | 1.75475140 |
| 136 | Squamous cell carcinoma (HP:0002860) | 1.73357896 |
| 137 | Amblyopia (HP:0000646) | 1.73020759 |
| 138 | Medial flaring of the eyebrow (HP:0010747) | 1.72846940 |
| 139 | Paralysis (HP:0003470) | 1.71834633 |
| 140 | Anencephaly (HP:0002323) | 1.69525953 |
| 141 | Gliosis (HP:0002171) | 1.67770323 |
| 142 | Colon cancer (HP:0003003) | 1.67535106 |
| 143 | Blindness (HP:0000618) | 1.65484847 |
| 144 | Sclerocornea (HP:0000647) | 1.65072020 |
| 145 | Abnormality of lateral ventricle (HP:0030047) | 1.64294456 |
| 146 | Esophageal atresia (HP:0002032) | 1.63170544 |
| 147 | Hypoplastic pelvis (HP:0008839) | 1.62794674 |
| 148 | Abnormality of the anterior horn cell (HP:0006802) | 1.62465125 |
| 149 | Degeneration of anterior horn cells (HP:0002398) | 1.62465125 |
| 150 | Amniotic constriction ring (HP:0009775) | 1.62283134 |
| 151 | Abnormality of placental membranes (HP:0011409) | 1.62283134 |
| 152 | Opisthotonus (HP:0002179) | 1.61572902 |
| 153 | CNS hypomyelination (HP:0003429) | 1.61010476 |
| 154 | Neutropenia (HP:0001875) | 1.58438806 |
| 155 | Hyperphosphaturia (HP:0003109) | 1.57666640 |
| 156 | Myokymia (HP:0002411) | 1.57663788 |
| 157 | Hypoplasia of the pons (HP:0012110) | 1.57185231 |
| 158 | Mutism (HP:0002300) | 1.55275505 |
| 159 | Redundant skin (HP:0001582) | 1.54858983 |
| 160 | Cortical visual impairment (HP:0100704) | 1.53200901 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TAOK2 | 5.41485824 |
| 2 | MAP4K1 | 4.48910661 |
| 3 | TNIK | 3.71962880 |
| 4 | MAPK15 | 3.24197828 |
| 5 | TXK | 2.92654333 |
| 6 | NME2 | 2.92627032 |
| 7 | VRK2 | 2.91759801 |
| 8 | STK16 | 2.91098753 |
| 9 | TGFBR2 | 2.28865421 |
| 10 | GRK7 | 2.25891528 |
| 11 | MAP4K2 | 1.96524162 |
| 12 | MUSK | 1.95743632 |
| 13 | MAP3K5 | 1.95174295 |
| 14 | PLK4 | 1.88677686 |
| 15 | ZAP70 | 1.88417559 |
| 16 | BCKDK | 1.85715610 |
| 17 | NLK | 1.83279683 |
| 18 | BTK | 1.77313072 |
| 19 | JAK3 | 1.75288591 |
| 20 | MAP2K7 | 1.70161991 |
| 21 | PIM2 | 1.65877696 |
| 22 | KIT | 1.63881903 |
| 23 | DYRK2 | 1.63700598 |
| 24 | NUAK1 | 1.63311502 |
| 25 | IKBKE | 1.63024907 |
| 26 | TEC | 1.60800671 |
| 27 | MAP2K6 | 1.57873666 |
| 28 | TYK2 | 1.49645749 |
| 29 | ITK | 1.47899379 |
| 30 | EEF2K | 1.45537102 |
| 31 | SIK2 | 1.45166889 |
| 32 | NEK1 | 1.45035786 |
| 33 | RPS6KB2 | 1.38917387 |
| 34 | STK10 | 1.35234916 |
| 35 | CDC7 | 1.33250667 |
| 36 | TBK1 | 1.32888429 |
| 37 | ACVR1B | 1.32693911 |
| 38 | BLK | 1.31507705 |
| 39 | MAP2K3 | 1.28796539 |
| 40 | KDR | 1.28462654 |
| 41 | MYLK | 1.27835249 |
| 42 | IKBKB | 1.27211402 |
| 43 | TGFBR1 | 1.26286133 |
| 44 | CSNK1G2 | 1.21080646 |
| 45 | NME1 | 1.19391912 |
| 46 | SYK | 1.18185096 |
| 47 | LCK | 1.17471858 |
| 48 | ABL2 | 1.15766933 |
| 49 | MAP3K12 | 1.15545038 |
| 50 | LRRK2 | 1.13068264 |
| 51 | IRAK4 | 1.12990079 |
| 52 | FGFR4 | 1.12055329 |
| 53 | CSF1R | 1.10505775 |
| 54 | CDK19 | 1.08577666 |
| 55 | BUB1 | 1.08541978 |
| 56 | TRIM28 | 1.08477667 |
| 57 | CDK8 | 1.08048757 |
| 58 | WNK3 | 1.06513947 |
| 59 | AURKA | 1.04566830 |
| 60 | PASK | 1.04377396 |
| 61 | ADRBK2 | 1.02738680 |
| 62 | MARK3 | 1.01288131 |
| 63 | TSSK6 | 1.01181691 |
| 64 | CSNK1A1L | 0.99116828 |
| 65 | DAPK3 | 0.95502580 |
| 66 | MAP2K2 | 0.95062479 |
| 67 | CLK1 | 0.94472846 |
| 68 | MAPKAPK5 | 0.93748004 |
| 69 | IRAK3 | 0.93721725 |
| 70 | IRAK1 | 0.93513224 |
| 71 | VRK1 | 0.91994790 |
| 72 | PBK | 0.89623420 |
| 73 | WEE1 | 0.89183707 |
| 74 | PLK1 | 0.89169762 |
| 75 | MAPKAPK3 | 0.88929657 |
| 76 | PDK2 | 0.88728390 |
| 77 | TESK2 | 0.88564012 |
| 78 | TNK2 | 0.87829239 |
| 79 | OBSCN | 0.87603304 |
| 80 | MOS | 0.87508103 |
| 81 | TLK1 | 0.82892369 |
| 82 | ATR | 0.82209541 |
| 83 | CDK3 | 0.81740731 |
| 84 | MAPK7 | 0.81693456 |
| 85 | MAP3K11 | 0.80481991 |
| 86 | FLT3 | 0.78927709 |
| 87 | PIK3CG | 0.78141133 |
| 88 | EIF2AK3 | 0.77794583 |
| 89 | TAF1 | 0.73492207 |
| 90 | TIE1 | 0.71904517 |
| 91 | RPS6KA5 | 0.71352831 |
| 92 | CCNB1 | 0.69528335 |
| 93 | MAPKAPK2 | 0.69388588 |
| 94 | MAPK4 | 0.69280794 |
| 95 | MAP3K7 | 0.67015882 |
| 96 | OXSR1 | 0.66982922 |
| 97 | LYN | 0.66870157 |
| 98 | CDK14 | 0.66848108 |
| 99 | MAPK11 | 0.66660405 |
| 100 | CAMK1 | 0.66602335 |
| 101 | HCK | 0.66597004 |
| 102 | PKN1 | 0.65619530 |
| 103 | DAPK1 | 0.64515291 |
| 104 | RPS6KA4 | 0.64169277 |
| 105 | TRPM7 | 0.63778391 |
| 106 | ILK | 0.63013543 |
| 107 | PINK1 | 0.62688344 |
| 108 | CSNK2A1 | 0.62513947 |
| 109 | CHEK2 | 0.62146369 |
| 110 | MAPK13 | 0.60763876 |
| 111 | MAPK12 | 0.60581845 |
| 112 | PRKD3 | 0.60494522 |
| 113 | PLK3 | 0.58645442 |
| 114 | CDK11A | 0.56617391 |
| 115 | ERN1 | 0.56590034 |
| 116 | BRAF | 0.56570126 |
| 117 | MKNK1 | 0.55173689 |
| 118 | PHKG1 | 0.54914182 |
| 119 | PHKG2 | 0.54914182 |
| 120 | BRSK1 | 0.54539992 |
| 121 | FES | 0.54039135 |
| 122 | CDK15 | 0.53468601 |
| 123 | EPHA3 | 0.53378451 |
| 124 | GRK1 | 0.52200160 |
| 125 | RPS6KA6 | 0.51508302 |
| 126 | SRPK1 | 0.51315731 |
| 127 | CDK18 | 0.50502665 |
| 128 | PRKCG | 0.50116310 |
| 129 | PAK1 | 0.50070905 |
| 130 | MAP3K8 | 0.49322623 |
| 131 | LIMK1 | 0.48958613 |
| 132 | DYRK3 | 0.48893615 |
| 133 | CSK | 0.48486097 |
| 134 | JAK1 | 0.48053876 |
| 135 | MARK1 | 0.47651828 |
| 136 | CSNK1G3 | 0.47129466 |
| 137 | PRKD2 | 0.46975383 |
| 138 | AURKB | 0.46655184 |
| 139 | HIPK2 | 0.46568600 |
| 140 | DAPK2 | 0.46343831 |
| 141 | PAK6 | 0.45252497 |
| 142 | YES1 | 0.45130164 |
| 143 | CDK7 | 0.43727848 |
| 144 | STK4 | 0.43115756 |
| 145 | CSNK1G1 | 0.42034801 |
| 146 | ZAK | 0.41636113 |
| 147 | CSNK2A2 | 0.41282821 |
| 148 | GRK5 | 0.40862743 |
| 149 | MST4 | 0.39976980 |
| 150 | EIF2AK2 | 0.39621981 |
| 151 | PRKCQ | 0.39545770 |
| 152 | RPS6KL1 | 0.39531393 |
| 153 | RPS6KC1 | 0.39531393 |
| 154 | ARAF | 0.39502457 |
| 155 | EPHB2 | 0.39302256 |
| 156 | TESK1 | 0.36947485 |
| 157 | INSRR | 0.36811402 |
| 158 | MAP3K4 | 0.36598966 |
| 159 | CSNK1A1 | 0.35964226 |
| 160 | GRK6 | 0.34851376 |
| 161 | TTK | 0.33434234 |
| 162 | MAP2K4 | 0.32582915 |
| 163 | MAP3K9 | 0.31428289 |
| 164 | PIM1 | 0.31273899 |
| 165 | TAOK3 | 0.30252472 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ribosome_Homo sapiens_hsa03010 | 6.54710107 |
| 2 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.46691994 |
| 3 | Proteasome_Homo sapiens_hsa03050 | 3.17153191 |
| 4 | RNA polymerase_Homo sapiens_hsa03020 | 2.46202384 |
| 5 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.45233975 |
| 6 | DNA replication_Homo sapiens_hsa03030 | 2.45131041 |
| 7 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 2.40237197 |
| 8 | Protein export_Homo sapiens_hsa03060 | 2.25709716 |
| 9 | Base excision repair_Homo sapiens_hsa03410 | 2.23493318 |
| 10 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.05003856 |
| 11 | Mismatch repair_Homo sapiens_hsa03430 | 2.04609641 |
| 12 | Sulfur relay system_Homo sapiens_hsa04122 | 2.04326381 |
| 13 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.92817498 |
| 14 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.90167441 |
| 15 | Parkinsons disease_Homo sapiens_hsa05012 | 1.83325648 |
| 16 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.81520407 |
| 17 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.76257538 |
| 18 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.72830504 |
| 19 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.69225002 |
| 20 | Homologous recombination_Homo sapiens_hsa03440 | 1.68306087 |
| 21 | Spliceosome_Homo sapiens_hsa03040 | 1.68077194 |
| 22 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.49145090 |
| 23 | Other glycan degradation_Homo sapiens_hsa00511 | 1.44035732 |
| 24 | Measles_Homo sapiens_hsa05162 | 1.39898662 |
| 25 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.32749014 |
| 26 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.30563514 |
| 27 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.28190774 |
| 28 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.23739213 |
| 29 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.22016808 |
| 30 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.21938779 |
| 31 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.20419642 |
| 32 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.19254142 |
| 33 | Alzheimers disease_Homo sapiens_hsa05010 | 1.17896465 |
| 34 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.16850237 |
| 35 | Leishmaniasis_Homo sapiens_hsa05140 | 1.15898343 |
| 36 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.15518222 |
| 37 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.15063148 |
| 38 | Purine metabolism_Homo sapiens_hsa00230 | 1.13068746 |
| 39 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.11888083 |
| 40 | RNA degradation_Homo sapiens_hsa03018 | 1.11620516 |
| 41 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.08994649 |
| 42 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.08679291 |
| 43 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.07813433 |
| 44 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.07572006 |
| 45 | Huntingtons disease_Homo sapiens_hsa05016 | 1.06487148 |
| 46 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.03685839 |
| 47 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.02598479 |
| 48 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.00101842 |
| 49 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.98790141 |
| 50 | Basal transcription factors_Homo sapiens_hsa03022 | 0.96886148 |
| 51 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.96655761 |
| 52 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.96229015 |
| 53 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.95480431 |
| 54 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.93228520 |
| 55 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.92877190 |
| 56 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.91530158 |
| 57 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.89924321 |
| 58 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.88923073 |
| 59 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.88512518 |
| 60 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.87826057 |
| 61 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.87791700 |
| 62 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.86451895 |
| 63 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.86154272 |
| 64 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.85014816 |
| 65 | Phototransduction_Homo sapiens_hsa04744 | 0.84849778 |
| 66 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.82104178 |
| 67 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.80883443 |
| 68 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.79736804 |
| 69 | Galactose metabolism_Homo sapiens_hsa00052 | 0.79478994 |
| 70 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.79194883 |
| 71 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.76998150 |
| 72 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.76686389 |
| 73 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.76667180 |
| 74 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.73625009 |
| 75 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.72204263 |
| 76 | Lysosome_Homo sapiens_hsa04142 | 0.69586541 |
| 77 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.66596962 |
| 78 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.65891391 |
| 79 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.64156371 |
| 80 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.63262288 |
| 81 | RNA transport_Homo sapiens_hsa03013 | 0.62812110 |
| 82 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.61927707 |
| 83 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.61534952 |
| 84 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.61183228 |
| 85 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.60343423 |
| 86 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.59900130 |
| 87 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.59121629 |
| 88 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.58737409 |
| 89 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.58691225 |
| 90 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.57870091 |
| 91 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.56668837 |
| 92 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.56443276 |
| 93 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.55757644 |
| 94 | Metabolic pathways_Homo sapiens_hsa01100 | 0.55671224 |
| 95 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.55492377 |
| 96 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.55107298 |
| 97 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.55102967 |
| 98 | Platelet activation_Homo sapiens_hsa04611 | 0.54945989 |
| 99 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.54845682 |
| 100 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.53949037 |
| 101 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.53586993 |
| 102 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.53584632 |
| 103 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.49300436 |
| 104 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.47812150 |
| 105 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.47637341 |
| 106 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.46531125 |
| 107 | Shigellosis_Homo sapiens_hsa05131 | 0.46361998 |
| 108 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.45769619 |
| 109 | Allograft rejection_Homo sapiens_hsa05330 | 0.45668820 |
| 110 | Carbon metabolism_Homo sapiens_hsa01200 | 0.45349208 |
| 111 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.44092461 |
| 112 | Salmonella infection_Homo sapiens_hsa05132 | 0.42563122 |
| 113 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.40100039 |
| 114 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.40041660 |
| 115 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.39110717 |
| 116 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.39090976 |
| 117 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.38119471 |
| 118 | HTLV-I infection_Homo sapiens_hsa05166 | 0.37468284 |
| 119 | Hepatitis B_Homo sapiens_hsa05161 | 0.37134229 |
| 120 | Apoptosis_Homo sapiens_hsa04210 | 0.36797517 |
| 121 | Pertussis_Homo sapiens_hsa05133 | 0.36569864 |
| 122 | Retinol metabolism_Homo sapiens_hsa00830 | 0.35070097 |
| 123 | Nicotine addiction_Homo sapiens_hsa05033 | 0.33832936 |
| 124 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.33598171 |
| 125 | Asthma_Homo sapiens_hsa05310 | 0.33070045 |
| 126 | Cell cycle_Homo sapiens_hsa04110 | 0.32835802 |
| 127 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.31676135 |
| 128 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.31470765 |
| 129 | Hepatitis C_Homo sapiens_hsa05160 | 0.30431399 |
| 130 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.29817243 |
| 131 | Influenza A_Homo sapiens_hsa05164 | 0.27229123 |
| 132 | Legionellosis_Homo sapiens_hsa05134 | 0.26230688 |
| 133 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.25798421 |
| 134 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.25668863 |
| 135 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.25359570 |
| 136 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.25339207 |
| 137 | Histidine metabolism_Homo sapiens_hsa00340 | 0.23247884 |
| 138 | Peroxisome_Homo sapiens_hsa04146 | 0.23028865 |
| 139 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.20185470 |
| 140 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.18140687 |

